Kolangitis

01Pathophysiology

The bile duct system normally maintains a low-pressure, sterile environment. Bile flows continuously from the liver through the hepatic ducts into the common bile duct and ultimately through the ampulla of Vater into the duodenum. The sphincter of Oddi acts as a one-way valve that normally prevents retrograde bacterial migration from the duodenum into the biliary tree.

Cholangitis develops when two conditions occur simultaneously: biliary obstruction and bacterial contamination. The most common cause of obstruction is a gallstone impacted in the common bile duct (choledocholithiasis), accounting for roughly 50 to 70 percent of cases. Other causes include malignant strictures, benign post-surgical strictures, and parasitic infections.

When the bile duct becomes obstructed, intraluminal pressure rises above the normal range of approximately 7 to 14 cmH2O. At pressures exceeding 25 cmH2O, the tight junctions between hepatocytes and bile canaliculi begin to break down. This allows bacteria that have colonized the stagnant bile to translocate directly into the hepatic sinusoids and systemic venous circulation, a process called cholangiovenous reflux. This is the mechanism that transforms a localized biliary infection into bacteremia and sepsis.

The organisms involved reflect their enteric origin. E. coli is the single most common pathogen, followed by Klebsiella and Enterococcus. In patients with prior biliary instrumentation or prolonged antibiotic exposure, resistant organisms and fungi become increasingly relevant. Polymicrobial infections are common, occurring in up to 50 percent of cases.

The pathophysiology directly explains every clinical feature. The fever and rigors result from bacteremia and systemic inflammatory response. The jaundice and cholestatic liver enzyme pattern (elevated ALP and direct bilirubin) result from bile flow obstruction. The RUQ pain results from biliary distension and inflammation of the duct wall. When the infection overwhelms the host response, septic shock and encephalopathy develop, completing the Reynolds pentad.

02Classification and Clinical Manifestation

The Tokyo Guidelines provide the standard severity grading system that directly guides treatment urgency:

The classic clinical presentations fall into recognizable patterns:

03Diagnostic Workup

The diagnostic approach follows a structured sequence. When a patient presents with the Charcot triad or Reynolds pentad, the clinical suspicion for cholangitis is already high. The first step is to draw CBC, hepatic function panel, and blood cultures before starting antibiotics. The lab pattern that should trigger immediate concern is a cholestatic pattern: ALP and direct bilirubin elevated out of proportion to transaminases. This distinguishes biliary obstruction from hepatocellular injury patterns seen in hepatitis.

The best initial imaging test is RUQ ultrasound. It is fast, non-invasive, widely available, and reliably demonstrates bile duct dilation. However, ultrasound has poor sensitivity for detecting the stone itself in the distal CBD because of overlying bowel gas. A dilated CBD on ultrasound in the setting of fever, jaundice, and cholestatic labs is sufficient to proceed directly to ERCP without further imaging.

When the clinical picture is ambiguous, meaning the patient has cholestatic labs but no clear Charcot triad or the ultrasound is equivocal, MRCP is the next step. MRCP provides a detailed map of the biliary tree without instrumentation, and it helps determine whether ERCP is necessary. This avoids the procedural risks of ERCP (pancreatitis, perforation, bleeding) in patients who may not actually have a stone.

ERCP occupies a unique role because it is both a diagnostic and therapeutic tool. In the context of cholangitis, ERCP is primarily performed for treatment (drainage), not for diagnosis alone. A critical testing point: you do not need a confirmed stone on imaging before performing ERCP if the clinical presentation strongly suggests cholangitis. The priority is decompressing the infected biliary system.

04Management and Treatment

Acute stabilization begins with standard sepsis management. IV fluids should be initiated immediately, and broad-spectrum antibiotics must be started before any imaging or procedures. The antibiotic choice must cover gram-negative enterics and anaerobes. Piperacillin-tazobactam is the most commonly recommended single-agent regimen because of its broad biliary penetration and coverage spectrum. For penicillin-allergic patients, a fluoroquinolone (ciprofloxacin or levofloxacin) combined with metronidazole is an acceptable alternative. Antibiotic duration is typically 4 to 7 days after successful source control; longer courses are indicated if bacteremia persists.

The cornerstone of management is biliary decompression, because antibiotics alone cannot resolve the infection without relieving the obstruction. The timing of drainage is severity-dependent:

For Grade I (mild), antibiotics may be started and the patient can be observed. If there is clinical improvement, ERCP can be scheduled on a semi-elective basis within 48 to 72 hours.

For Grade II (moderate), drainage should be performed within 24 to 48 hours. Delaying beyond this window increases the risk of clinical deterioration.

For Grade III (severe), biliary drainage is emergent and should be performed as soon as technically feasible after initial hemodynamic stabilization. These patients often require ICU admission, vasopressors, and aggressive resuscitation before and during the procedure.

ERCP with endoscopic sphincterotomy is the first-line drainage method. During ERCP, the endoscopist can extract the obstructing stone, place a biliary stent if the stone cannot be completely cleared, and perform sphincterotomy to widen the ampullary opening. If the patient has surgically altered anatomy (such as a Roux-en-Y gastric bypass) that makes endoscopic access to the ampulla impossible, percutaneous transhepatic biliary drainage (PTBD) is the alternative.

After the acute episode resolves, patients with gallstone-related cholangitis should undergo interval cholecystectomy to prevent recurrent stone formation and future episodes. This is typically performed during the same hospitalization or within 2 to 4 weeks.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get questions about cholangitis wrong is by confusing it with acute cholecystitis or uncomplicated choledocholithiasis. The critical distinction is that cholangitis requires the combination of biliary obstruction plus infection. A vignette describing RUQ pain with jaundice and cholestatic labs but no fever points toward choledocholithiasis, not cholangitis. A vignette with RUQ pain and fever but no jaundice and no duct dilation points toward cholecystitis.

Another frequent trap involves the management sequence. Students often select "antibiotics" as the single best answer, but antibiotics alone are insufficient without biliary drainage. Conversely, selecting ERCP as the immediate next step before initiating antibiotics is also incorrect. The tested logic is: resuscitate and start antibiotics first, then decompress the biliary tree. The next best step for a patient already on antibiotics who is not improving is always biliary drainage, not switching antibiotics.

A third high-yield pearl involves the elderly or immunocompromised patient who presents with an incomplete Charcot triad. The vignette may describe a confused elderly patient with a low-grade fever and abnormal LFTs but no RUQ pain and no obvious jaundice. The test is assessing whether you can recognize atypical cholangitis when the classic triad is absent. The cholestatic lab pattern combined with any systemic sign of infection in the presence of a dilated bile duct should trigger the diagnosis.

Finally, students sometimes confuse the roles of MRCP and ERCP. MRCP is the best non-invasive diagnostic test when the diagnosis is uncertain. ERCP is reserved for when you are ready to intervene. Ordering ERCP "just to look" is penalized on exams because it carries procedural risks (post-ERCP pancreatitis in 3 to 7 percent of cases). If the question asks for the most appropriate next diagnostic step and clinical suspicion is intermediate, the answer is MRCP. If clinical suspicion is high and the patient needs decompression, the answer is ERCP.